Pharaoh Neuro is developing technologies that give physicians and the patients they treat improved options during the most critical moments in neurointerventional care.
Our technologies
Each Pharaoh Neuro technology addresses a different moment in neurocritical care.
Available Now
MindsEye® Expandable Port
First and only expandable brain port.
Small insertion diameter.
Large working channel.
Investigational-FDA Breakthrough Device Designation
Neurapheresis™ CSF Management System
The Neurapheresis System is intended for filtration of CSF and is indicated for the accelerated removal of blood and blood-breakdown products from the CSF of patients following aneurysmal subarachnoid hemorrhage (aSAH).
What’s New
Pharaoh Neuro Receives FDA Breakthrough Device Designation for Neurapheresis
The designation recognizes the potential of the Neurapheresis system to address an unmet need in CSF management for patients with serious neurological conditions. It provides access to the FDA's Total Product Lifecycle Advisory Program (TAP) and Sprint process for expedited interaction during development and review.
PILLAR-XT Trial Results Published
The PILLAR-XT study, led by Spiros L. Blackburn, MD, of McGovern Medical School at UTHealth Houston, demonstrated that active CSF filtration can accelerate the removal of blood and blood breakdown products from the cerebrospinal fluid in patients with aneurysmal subarachnoid hemorrhage.
Mike Blue Joins the Board of Directors of Pharaoh Neuro
Pharaoh Neuro, a medical device company developing active CSF solutions for neurocritical care, today announced the appointment of Mike Blue to its Board of Directors. Blue brings more than 25 years of leadership experience in medical devices.
Guided by science, shaped by experience, and focused on transforming neurocritical care.
Our leadership team is committed to transforming neurocritical care through active CSF solutions, and to keeping patients at the center of every decision we make.
Amaza Reitmeier
Chief Executive Officer, Director
Dr. Nandan Lad
Chief Medical Officer & Co-Founder
Dr. Aaron McCabe
Chief Scientific & Technology Officer
Tali Neidenfeuhr
Systems Engineer
Blake Hedstrom
General Manager – MindsEye
Amaza Reitmeier
Chief Executive Officer, Director
Dr. Nandan Lad
Chief Medical Officer & Co-Founder
Dr. Aaron McCabe
Chief Scientific & Technology Officer
Tali Neidenfeuhr
Systems Engineer
Blake Hedstrom
General Manager – MindsEye
Amaza Reitmeier
Chief Executive Officer, Director
Dr. Nandan Lad
Chief Medical Officer & Co-Founder
Dr. Aaron McCabe
Chief Scientific & Technology Officer
Tali Neidenfeuhr
Systems Engineer
Blake Hedstrom
General Manager – MindsEye
Partners
Powered by investors who are committed to advancing solutions that protect the brain
